Beyond Meat Delays Earnings to Handle Major Asset Write-Down
Plant-based meat maker Beyond Meat (BYND) delayed its Q3 earnings release to calculate a massive asset write-down.
Already have an account? Sign in.
Plant-based meat maker Beyond Meat (BYND) delayed its Q3 earnings release to calculate a massive asset write-down.
argenx shares fell after it stopped a Phase 3 Sjögren’s trial for futility, even as FB102 met its Phase 2 goal in celiac disease.
05:29 AM — Dow poised to fall 400 points, while S&P 500 and Nasdaq face declines as oil prices surge amid renewed fears of war in Iran.
The oral drug remains investigational; cadisegliatin stays the lead program.
Be the first to know when deals break, stocks move, or biotech headlines hit.